Confirmatory Study Nepafenac 0.3%
| Status: | Archived |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | July 2010 |
The purpose of this study is to assess the safety and efficacy of a new investigational eye
drop called Nepafenac Ophthalmic Suspension, 0.3% for the prevention and treatment of
inflammation (swelling and redness) and pain in the eye after cataract extraction.
We found this trial at
1
site
Alcon Call Center Alcon is helping people see the world better through advanced surgical, pharmaceutical...
Click here to add this to my saved trials
